COST-EFFECTIVENESS ANALYSIS OF SURFACTANT THERAPY FOR THE TREATMENT OF RESPIRATORY DISTRESS SYNDROME NEWBORN IN THE RUSSIAN FEDERATION

被引：2
|
作者：
Yagudina, R. [1 ]
Kulikov, A. [1 ]
Serpik, V [1 ]
机构：
[1] IM Sechenov First Moscow State Med Univ, Moscow, Russia
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.2444
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS50
引用
收藏
页码：S412 / S412
页数：1
相关论文
共 50 条
  • [1] THE COST-EFFECTIVENESS OF SYNTHETIC SURFACTANT THERAPY FOR NEONATAL RESPIRATORY-DISTRESS SYNDROME
    PHIBBS, CS
    PHIBBS, RH
    TOOLEY, WH
    WAKELEY, A
    SNIDERMAN, S
    CLINICAL RESEARCH, 1990, 38 (01): : A178 - A178
  • [2] Analysis of the cost-effectiveness of surfactant treatment (Curosurf®) in respiratory distress syndrome therapy in preterm infants: early treatment compared to late treatment
    Dani, Carlo
    Ravasio, Roberto
    Fioravanti, Leonardo
    Circelli, Maria
    ITALIAN JOURNAL OF PEDIATRICS, 2014, 40
  • [3] Analysis of the cost-effectiveness of surfactant treatment (Curosurf®) in respiratory distress syndrome therapy in preterm infants: early treatment compared to late treatment
    Carlo Dani
    Roberto Ravasio
    Leonardo Fioravanti
    Maria Circelli
    Italian Journal of Pediatrics, 40
  • [4] COST-EFFECTIVENESS ANALYSIS OF FORMOTEROL FOR ASTHMA TREATMENT IN RUSSIAN FEDERATION
    Kulikov, A.
    Makarova, E.
    VALUE IN HEALTH, 2016, 19 (03) : A115 - A116
  • [5] COST-EFFECTIVENESS ANALYSIS OF SECUKINUMAB IN THE TREATMENT OF PSORIATIC ARTHRITIS IN THE RUSSIAN FEDERATION
    Yagudina, R.
    Kulikov, A.
    Protsenko, M.
    Serpik, V
    VALUE IN HEALTH, 2019, 22 : S905 - S905
  • [6] URAPIDIL IN TREATMENT OF HYPERTENSION URGENCIES IN THE RUSSIAN FEDERATION: COST-EFFECTIVENESS ANALYSIS
    Kulikov, A.
    Protsenko, M.
    Misikova, B.
    VALUE IN HEALTH, 2012, 15 (04) : A121 - A121
  • [7] Cost-effectiveness comparison of three different natural surfactant preparations in the treatment of preterm infants with respiratory distress syndrome
    Akin, Mustafa Senol
    Cakir, Ufuk
    CUKUROVA MEDICAL JOURNAL, 2025, 50 (01): : 73 - 82
  • [8] COST-EFFECTIVENESS ANALYSIS OF DACLATASVIR WITH ASUNAPREVIR IN TREATMENT OF CHRONIC HEPATITIS C IN THE RUSSIAN FEDERATION
    Yagudina, R.
    Kulikov, A.
    Babiy, V. V.
    VALUE IN HEALTH, 2016, 19 (07) : A415 - A415
  • [9] COST-EFFECTIVENESS OF BERACTANT IN THE PREVENTION OF RESPIRATORY-DISTRESS SYNDROME
    SOLL, RF
    JACOBS, J
    PASHKO, S
    THOMAS, R
    PHARMACOECONOMICS, 1993, 4 (04) : 278 - 286
  • [10] COST-EFFECTIVENESS ANALYSIS OF BOSENTAN AND SILDENAFIL COMPARED WITH STANDARD THERAPY IN TREATMENT OF PRIMARY PULMONARY ARTERIAL HYPERTENSION IN RUSSIAN FEDERATION
    Omelyanovsky, V
    Avxentyeva, M.
    Krysanov, I
    Goryaynov, S.
    Ivakhnenko, O.
    Tsfasman, F. M.
    VALUE IN HEALTH, 2011, 14 (07) : A367 - A367
12345